BlackRock
IMGN

BlackRock’s Immunogen Inc IMGN Stock Holding History

BlackRock’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,824,392
Closed -$647M – 5465
2023
Q4 		$647M Buy
21,824,392
+1,550,533
+8% +$30.9M 0.02% 806
2023
Q3 		$322M Sell
20,273,859
-631,127
-3% -$10.5M 0.01% 1222
2023
Q2 		$394M Buy
20,904,986
+2,908,657
+16% +$34.3M 0.01% 1105
2023
Q1 		$69.1M Sell
17,996,329
-19,673
-0.1% -$83.9K ﹤0.01% 2245
2022
Q4 		$89.4M Buy
18,016,002
+570,976
+3% +$3.1M ﹤0.01% 2068
2022
Q3 		$83.4M Sell
17,445,026
-432,243
-2% -$2.28M ﹤0.01% 2089
2022
Q2 		$80.4M Buy
17,877,269
+1,444,336
+9% +$6.27M ﹤0.01% 2169
2022
Q1 		$78.2M Buy
16,432,933
+1,569,629
+11% +$8.69M ﹤0.01% 2296
2021
Q4 		$110M Sell
14,863,304
-518,571
-3% -$3.22M ﹤0.01% 2161
2021
Q3 		$87.2M Sell
15,381,875
-34,571
-0.2% -$200K ﹤0.01% 2307
2021
Q2 		$102M Sell
15,416,446
-889,140
-5% -$6.2M ﹤0.01% 2237
2021
Q1 		$132M Buy
16,305,586
+1,149,004
+8% +$9.38M ﹤0.01% 2015
2020
Q4 		$97.8M Buy
15,156,582
+1,423,482
+10% +$8.3M ﹤0.01% 2097
2020
Q3 		$49.4M Sell
13,733,100
-710,296
-5% -$2.87M ﹤0.01% 2309
2020
Q2 		$66.4M Buy
14,443,396
+821,410
+6% +$3.49M ﹤0.01% 2090
2020
Q1 		$46.5M Buy
13,621,986
+1,439,997
+12% +$6.3M ﹤0.01% 2093
2019
Q4 		$62.2M Buy
12,181,989
+89,552
+0.7% +$304K ﹤0.01% 2227
2019
Q3 		$29.3M Buy
12,092,437
+146,544
+1% +$389K ﹤0.01% 2603
2019
Q2 		$25.9M Sell
11,945,893
-371,003
-3% -$877K ﹤0.01% 2697
2019
Q1 		$33.4M Sell
12,316,896
-61,308
-0.5% -$266K ﹤0.01% 2509
2018
Q4 		$59.4M Buy
12,378,204
+896,227
+8% +$5.44M ﹤0.01% 2133
2018
Q3 		$109M Buy
11,481,977
+1,045,627
+10% +$10.1M ﹤0.01% 1914
2018
Q2 		$102M Buy
10,436,350
+2,079,732
+25% +$21.9M ﹤0.01% 1926
2018
Q1 		$87.9M Sell
8,356,618
-113,479
-1% -$1.12M ﹤0.01% 1936
2017
Q4 		$54.3M Buy
8,470,097
+2,996,116
+55% +$18.5M ﹤0.01% 2238
2017
Q3 		$41.9M Buy
5,473,981
+89,036
+2% +$592K ﹤0.01% 2388
2017
Q2 		$38.3M Buy
5,384,945
+16,846
+0.3% +$77.1K ﹤0.01% 2415
2017
Q1 		$20.8M Buy
5,368,099
+5,360,543
+70,944% +$15.6M ﹤0.01% 2733
2016
Q4 		$16K Sell
7,556
-1,116
-13% -$2.24K ﹤0.01% 3307
2016
Q3 		$23K Sell
8,672
-8,961
-51% -$26.1K ﹤0.01% 3253
2016
Q2 		$55K Buy
17,633
+11,835
+204% +$74.2K ﹤0.01% 2890
2016
Q1 		$50K Buy
5,798
+3,010
+108% +$25.5K ﹤0.01% 2355
2015
Q4 		$38K Buy
2,788
+468
+20% +$5.76K ﹤0.01% 2212
2015
Q3 		$22K Hold
2,320
– – ﹤0.01% 2337
2015
Q2 		$34K Sell
2,320
-151
-6% -$1.66K ﹤0.01% 2151
2015
Q1 		$22K Hold
2,471
– – ﹤0.01% 2329
2014
Q4 		$15K Hold
2,471
– – ﹤0.01% 2520
2014
Q3 		$27K Hold
2,471
– – ﹤0.01% 2190
2014
Q2 		$29K Sell
2,471
-253
-9% -$3.18K ﹤0.01% 2201
2014
Q1 		$41K Hold
2,724
– – ﹤0.01% 2011
2013
Q4 		$40K Hold
2,724
– – ﹤0.01% 2017
2013
Q3 		$46K Hold
2,724
– – ﹤0.01% 1870
2013
Q2 		$45K Buy
+2,724
New +$44.1K ﹤0.01% 1900

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

BlackRock's IMGN Position: Q1 2024 in Review

BlackRock sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 21,824,392 shares — an estimated $647M sold.

BlackRock first reported a position in IMGN in Q2 2013 and held it in 43 quarters. The position peaked at $647M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • BlackRock reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • BlackRock sold 21,824,392 Immunogen Inc shares in Q1 2024, an estimated $647M.
  • BlackRock first reported a position in Immunogen Inc in Q2 2013 and held it in 43 quarters.
  • BlackRock's Immunogen Inc position peaked at $647M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on BlackRock's 13F filing for Q1 2024, filed 10 May 2024.